SciClone Pharmaceuticals IPO Initiation: A Hard Sell
SciClone is pre-marketing a Hong Kong IPO to raise $500 million, according to press reports. Overall, on a fundamental basis, we are inclined to...
576 Views
I-Mab Placement - Heading in the Right Direction
A group of shareholders plans to raise around US$200m via selling a 4.6% stake in I-Mab (IMAB US). We have previously covered the IPO as well.
334 Views
BlueBird (BIRD): Flying Higher
At 9.8 EV/EBITDA and 0.73 PBR, Blue Bird (BIRD IJ) is currently trading at 42% and 44% discount in EV/EBITDA and PBR compared to its peers despite...
563 Views
Parkway Pantai: Attraction from Vaccination
Attractive valuation in expectation of a call in July 2022 and vaccination effects on the hospital visits across the border from Indonesia
595 Views
Medtecs Led Most Traded Catalist Stocks in 2020
Combined, the 10 most traded Catalist stocks in the 2020 year-to-14 Dec have seen more than S$50 million in turnover a day and include as many...
1.2k Views